Cognition Therapeutics, Inc. Profile Avatar - Palmy Investing

Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead…

Biotechnology
US, Purchase [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Cognition Therapeutics, Inc. (CGTX) to it's peer group.

Peer Group
Loading...
End of CGTX's Analysis
CIK: 1455365 CUSIP: 19243B102 ISIN: US19243B1026 LEI: - UEI: -
Secondary Listings
CGTX has no secondary listings inside our databases.